Enliven Therapeutics, Inc. — SCHEDULE 13G/A Filings
7 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Enliven Therapeutics, Inc. (ELVN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Enliven Therapeutics, Inc. has filed 7 SCHEDULE 13G/A documents with the SEC since 2016. To view all SEC filings by Enliven Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001738048-25-000018 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002752 | Nov 5, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-078568 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001831942-25-000011 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-003029 | Jul 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-013999 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-000912 | Feb 14, 2025 | — |